Ivax prepares prospectus for 100% Polfa Kutno share call

American pharmaceutical producer Ivax has taken over 24.99% of Polfa Kutno's shares after buying a subsidiary company from Italy's Recordati. The purchase of the shares, worth zł.340 a piece, will be paid for using Ivax's own shares and marks the end of the two-month battle between Ivax and Recordati for control of the domestic pharmaceutical firm. "After these stocks are permitted to trade, Ivax will announce a call, only to pay for Polfa Kutno's shares with its own shares," said Przemysław Szmyt of Trigon, a company which has been advising Ivax on the Polfa Kutno deal. Thus Ivax has returned to its original idea to announce only one call for 100% of Polfa Kutno's stock, the prospectus for which is currently being prepared and should be ready by mid-June. (Puls Biznesu, pp. 1, 11) D.W.